These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7745499)

  • 1. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast.
    Harrison M; Magee HM; O'Loughlin J; Gorey TF; Dervan PA
    J Pathol; 1995 Mar; 175(3):303-9. PubMed ID: 7745499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS.
    Moore E; Magee H; Coyne J; Gorey T; Dervan PA
    J Pathol; 1999 Mar; 187(4):403-9. PubMed ID: 10398098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
    Visscher DW; Wallis TL; Crissman JD
    Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.
    Marinho AF; Botelho M; Schmitt FC
    Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
    Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ
    J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells.
    Balazs M; Matsumura K; Moore D; Pinkel D; Gray JW; Waldman FM
    Cytometry; 1995 May; 20(1):62-73. PubMed ID: 7600900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
    Mendelin J; Grayson M; Wallis T; Visscher DW
    Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast.
    Susnik B; Worth A; Palcic B; Poulin N; LeRiche J
    Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.
    Munn KE; Walker RA; Varley JM
    Oncogene; 1995 Apr; 10(8):1653-7. PubMed ID: 7731721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
    J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
    Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
    Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
    Kapranos N; Kounelis S; Karantasis H; Kouri E
    Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.
    Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Kallioniemi OP; Isola J
    Am J Pathol; 1997 Apr; 150(4):1465-71. PubMed ID: 9095001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
    Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
    Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.